Inventor · disambiguated record

Boyd L. Harrison

Also filed as: DOLFINI JOSEPH E · HARRISON BOYD · HARRISON BOYD L · HARRISON BOYD LYNN

95 granted patents·55 pending applications·1,041 citations·filing 1978–2025

99Inventor score

Technology areasA61P C07J A61K C07D C07C

Files withSAGE THERAPEUTICS INC109 WYETH CORP15 RICHARDSON MERRELL INC7 MERRELL DOW PHARMA6 MERRELL PHARMA INC4

Top patents by PatentIndex Score

150 records

0199US11530237B2Compositions and methods for treating CNS disordersSAGE THERAPEUTICS INC·Filed 2020·Granted Dec 20, 2022·9 cites·4 claims
0299US11149057B2Neuroactive steroids, compositions, and uses thereofSAGE THERAPEUTICS INC·Filed 2020·Granted Oct 19, 2021·9 cites·33 claims
0399US10723758B2Oxysterols and methods of use thereofSAGE THERAPEUTICS INC·Filed 2018·Granted Jul 28, 2020·20 cites·2 claims
0499US10246482B2Neuroactive steroids, compositions, and uses thereofSAGE THERAPEUTICS INC·Filed 2015·Granted Apr 2, 2019·38 cites·85 claims
0598US11905309B2Neuroactive steroids and methods of use thereofSAGE THERAPEUTICS INC·Filed 2021·Granted Feb 20, 2024·5 cites·18 claims
0698US11878995B2Oxysterols and methods of use thereofSAGE THERAPEUTICS INC·Filed 2022·Granted Jan 23, 2024·5 cites·16 claims
0798US11613556B2Oxysterols and methods of use thereofSAGE THERAPEUTICS INC·Filed 2021·Granted Mar 28, 2023·6 cites·20 claims
0898US11542297B2Compositions and methods for treating CNS disordersSAGE THERAPEUTICS INC·Filed 2022·Granted Jan 3, 2023·9 cites·28 claims
0998US11241446B219-nor C3, 3-disubstituted C21-N-pyrazolyl steroids and methods of use thereofSAGE THERAPEUTICS INC·Filed 2019·Granted Feb 8, 2022·12 cites·15 claims
1098US11149054B2Oxysterols and methods of use thereofSAGE THERAPEUTICS INC·Filed 2017·Granted Oct 19, 2021·14 cites·8 claims
1198US11111266B2Oxysterols and methods of use thereofSAGE THERAPEUTICS INC·Filed 2017·Granted Sep 7, 2021·15 cites·25 claims
1298US11104701B2Neuroactive steroids and methods of use thereofSAGE THERAPEUTICS INC·Filed 2018·Granted Aug 31, 2021·16 cites·24 claims
1398US10870677B2Compositions and methods for treating CNS disordersSAGE THERAPEUTICS INC·Filed 2019·Granted Dec 22, 2020·13 cites·1 claims
1498US10259840B2Oxysterols and methods of use thereofSAGE THERAPEUTICS INC·Filed 2015·Granted Apr 16, 2019·30 cites·3 claims
1598US10227375B2Neuroactive steroids and methods of use thereofSAGE THERAPEUTICS INC·Filed 2018·Granted Mar 12, 2019·33 cites·4 claims
1698US9512165B219-nor C3, 3-disubstituted C21-N-pyrazolyl steroids and methods of use thereofSAGE THERAPEUTICS INC·Filed 2014·Granted Dec 6, 2016·71 cites·2 claims
1797US11926646B2C7 substituted oxysterols and methods of use thereofSAGE THERAPEUTICS INC·Filed 2021·Granted Mar 12, 2024·5 cites·11 claims
1897US11884697B2Oxysterols and methods of use thereofSAGE THERAPEUTICS INC·Filed 2021·Granted Jan 30, 2024·6 cites·27 claims
1997US11780875B2Neuroactive steroids, compositions, and uses thereofSAGE THERAPEUTICS INC·Filed 2021·Granted Oct 10, 2023·4 cites·20 claims
2097US11732000B2Oxysterols and methods of use thereofSAGE THERAPEUTICS INC·Filed 2021·Granted Aug 22, 2023·6 cites·12 claims
2197US11498940B2Neuroactive steroids, compositions, and uses thereofSAGE THERAPEUTICS INC·Filed 2020·Granted Nov 15, 2022·8 cites·30 claims
2297US11407782B2Oxysterols and methods of use thereofSAGE THERAPEUTICS INC·Filed 2020·Granted Aug 9, 2022·5 cites·22 claims
2397US10822370B219-nor neuroactive steroids and methods of use thereofSAGE THERAPEUTICS INC·Filed 2018·Granted Nov 3, 2020·13 cites·24 claims
2497US10774108B2Compositions and methods for treating CNS disordersSAGE THERAPEUTICS INC·Filed 2015·Granted Sep 15, 2020·12 cites·18 claims
2597US10759828B2Neuroactive steroids, compositions, and uses thereofSAGE THERAPEUTICS INC·Filed 2018·Granted Sep 1, 2020·15 cites·1 claims
2697US10745436B2Neuroactive steroids, compositions, and uses thereofSAGE THERAPEUTICS INC·Filed 2019·Granted Aug 18, 2020·9 cites·30 claims
2797US10342810B219-nor C3, 3-disubstituted C21-N-pyrazolyl steroids and methods of use thereofSAGE THERAPEUTICS INC·Filed 2018·Granted Jul 9, 2019·17 cites·16 claims
2897US10172871B219-nor C3, 3-disubstituted C21-N-pyrazolyl steroids and methods of use thereofSAGE THERAPEUTICS INC·Filed 2016·Granted Jan 8, 2019·20 cites·12 claims
2997US9725481B219-nor C3, 3-disubstituted C21-C-bound heteroaryl steroids and methods of use thereofSAGE THERAPEUTICS INC·Filed 2014·Granted Aug 8, 2017·46 cites·26 claims
3097US9365611B219-NOR neuroactive steroids and methods of use thereofSAGE THERAPEUTICS INC·Filed 2014·Granted Jun 14, 2016·49 cites·25 claims
3196US12129276B2Oxysterols and methods of use thereofSAGE THERAPEUTICS INC·Filed 2023·Granted Oct 29, 2024·2 cites·20 claims
3296US11945836B2Compositions and methods for treating CNS disordersSAGE THERAPEUTICS INC·Filed 2022·Granted Apr 2, 2024·3 cites·20 claims
3396US11851457B2Oxysterols and methods of use thereofSAGE THERAPEUTICS INC·Filed 2021·Granted Dec 26, 2023·4 cites·18 claims
3496US11344563B219-nor C3, 3-disubstituted C21-C-bound heteroaryl steroids and methods of use thereofSAGE THERAPEUTICS INC·Filed 2019·Granted May 31, 2022·8 cites·20 claims
3596US11279730B2Oxysterols and methods of use thereofSAGE THERAPEUTICS INC·Filed 2020·Granted Mar 22, 2022·5 cites·13 claims
3696US11147877B2Compositions and methods for treating CNS disordersSAGE THERAPEUTICS INC·Filed 2019·Granted Oct 19, 2021·8 cites·12 claims
3796US11046728B2Neuroactive steroids, compositions, and uses thereofSAGE THERAPEUTICS INC·Filed 2019·Granted Jun 29, 2021·8 cites·14 claims
3895US12180247B2Oxysterols and methods of use thereofSAGE THERAPEUTICS INC·Filed 2023·Granted Dec 31, 2024·2 cites·12 claims
3995US10329320B2Neuroactive steroids, compositions, and uses thereofSAGE THERAPEUTICS INC·Filed 2016·Granted Jun 25, 2019·18 cites·25 claims
4094US12473327B2Neuroactive steroids, compositions and uses thereofSAGE THERAPEUTICS INC·Filed 2023·Granted Nov 18, 2025·1 cites·16 claims
4194US12129275B2Neuroactive steroids, compositions, and uses thereofSAGE THERAPEUTICS INC·Filed 2022·Granted Oct 29, 2024·2 cites·18 claims
4294US10577390B2Compositions and methods for treating CNS disordersSAGE THERAPEUTICS INC·Filed 2015·Granted Mar 3, 2020·10 cites·3 claims
4394US10435431B23,3 disubstituted 19-nor pregnane compounds, compositions, and uses thereofSAGE THERAPEUTICS INC·Filed 2017·Granted Oct 8, 2019·10 cites·1 claims
4494US10323059B2Neuroactive steroids, compositions, and uses thereofSAGE THERAPEUTICS INC·Filed 2017·Granted Jun 18, 2019·12 cites·7 claims
4593US11124538B2Neuroactive steroids, compositions, and uses thereofSAGE THERAPEUTICS INC·Filed 2019·Granted Sep 21, 2021·9 cites·35 claims
4693US10752653B2Oxysterols and methods of use thereofSAGE THERAPEUTICS INC·Filed 2017·Granted Aug 25, 2020·4 cites·13 claims
4793US10391106B219-nor C3, 3-disubstituted C21-C-bound heteroaryl steroids and methods of use thereofSAGE THERAPEUTICS INC·Filed 2017·Granted Aug 27, 2019·10 cites·3 claims
4893US10023606B219-nor neuroactive steroids and methods of use thereofSAGE THERAPEUTICS INC·Filed 2016·Granted Jul 17, 2018·11 cites·28 claims
4992US11261211B219-NOR neuroactive steroids and methods of use thereofSAGE THERAPEUTICS INC·Filed 2019·Granted Mar 1, 2022·8 cites·24 claims
5091US10426837B2Compositions and methods for treating CNS disordersSAGE THERAPEUTICS INC·Filed 2017·Granted Oct 1, 2019·8 cites·10 claims

Showing the top 50 of 150 patent records by PatentIndex Score.

Join the waitlist — get patent alerts

Get an alert when Boyd L. Harrison files or is granted a new patent.

We store only your email — no account needed. See our privacy policy.

Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →